Literature DB >> 30958370

A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio.

Qiongqiong Qiu1, Luxi Shen1, Longfei Jia1,2,3,4,5,6, Qi Wang1,2,3,4,5,6, Fangyu Li1,2,3,4,5,6, Ying Li1,2,3,4,5,6, Jianping Jia1,2,3,4,5,6.   

Abstract

BACKGROUND: Presenilin1 (PSEN1) is the most common gene related to familial Alzheimer's disease (AD). Only several mutation types from Chinese have been reported, with less biological function research conducted.
OBJECTIVES: We explore the pathological function of PSEN1 M139L, a mutation located at α-helix of PSEN1 transmembrane 2, using predictive programs and in vitro study and compare its effects on Aβ production to those of an artificial PSEN1 S141G located at non α-helix mutation face.
METHODS: APP, PSEN1, and PSEN2 genes were screened for mutations using Sanger sequencing in the DNA samples of the proband and additional available family members. Disease-mutation cosegregation analysis and three software programs were performed to predict the mutation's pathogenicity. In vitro, we investigated the impact of these mutations on Aβ production in HEK293-APPswe cells using lentiviral vectors harboring PSEN1 WT, PSEN1 M139L, the positive control (PSEN1 M139V) and the non α-helical mutation (PSEN1 S141G). In addition, we co-transfected PSEN1 and tau into cells to determine the mutations' impact on tau phosphorylation.
RESULTS: PSEN1 M139L mutation was discovered in the index patient and four affected siblings. Cosegregation analysis and silicon prediction suggested the mutation was probably disease causing. In vitro studies demonstrated that both PSEN1 M139L and PSEN1 S141G caused elevated ratios of Aβ42/Aβ40, but changes of tau phosphorylation were not detected.
CONCLUSION: The novel PSEN1 M139L mutation found in familial AD increases the Aβ42/Aβ40 ratio significantly. Mutations at non α-helical mutation face of PSEN1 TM2 can affect Aβ production and the region may play a key role in PSEN1 function.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-βzzm321990; mutation; presenilin; α-helix

Year:  2019        PMID: 30958370     DOI: 10.3233/JAD-181291

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

1.  [Progress on loss-of-function hypothesis of presenilin-1 mutations in Alzheimer diseases].

Authors:  Min Yan; Xu Wang; Xihan Guo
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-08-25

2.  Microtube Array Membrane Encapsulated Cell Therapy: A Novel Platform Technology Solution for Treatment of Alzheimer's Disease.

Authors:  Shu-Mei Chen; Tsung-Chin Hsu; Chee-Ho Chew; Wan-Ting Huang; Amanda Lin Chen; Yung-Feng Lin; Sabiha Eddarkaoui; Luc Buee; Chien-Chung Chen
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

3.  A Rare Variation in the 3' Untranslated Region of the Presenilin 2 Gene Is Linked to Alzheimer's Disease.

Authors:  Yana Pang; Tingting Li; Qi Wang; Wei Qin; Ying Li; Yiping Wei; Longfei Jia
Journal:  Mol Neurobiol       Date:  2021-05-19       Impact factor: 5.590

Review 4.  Is Alzheimer's Disease a Liver Disease of the Brain?

Authors:  Margaret F Bassendine; Simon D Taylor-Robinson; Michael Fertleman; Michael Khan; Dermot Neely
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 5.  The Genetics of Alzheimer's Disease in the Chinese Population.

Authors:  Chen-Ling Gan; Tao Zhang; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

Review 6.  Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status.

Authors:  Qi Qin; Yunsi Yin; Yan Wang; Yuanyuan Lu; Yi Tang; Jianping Jia
Journal:  Mol Genet Genomic Med       Date:  2020-08-06       Impact factor: 2.183

7.  Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage.

Authors:  Longfei Jia; Min Zhu; Chaojun Kong; Yana Pang; Heng Zhang; Qiongqiong Qiu; Cuibai Wei; Yi Tang; Qi Wang; Ying Li; Tingting Li; Fangyu Li; Qigeng Wang; Yan Li; Yiping Wei; Jianping Jia
Journal:  Alzheimers Dement       Date:  2020-08-10       Impact factor: 21.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.